These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 16255665
1. Safety and efficacy of growth hormone replacement therapy in adults. Toogood A. Expert Opin Drug Saf; 2005 Nov; 4(6):1069-82. PubMed ID: 16255665 [Abstract] [Full Text] [Related]
2. Management of growth hormone deficiency in adults. Nilsson AG, Svensson J, Johannsson G. Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530 [Abstract] [Full Text] [Related]
3. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement. Christ ER, Carroll PV, Russell-Jones DL, Sönksen PH. Schweiz Med Wochenschr; 1997 Aug 30; 127(35):1440-9. PubMed ID: 9297747 [Abstract] [Full Text] [Related]
4. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults. Cenci MC, Conceição FL, Soares DV, Spina LD, Brasil RR, Lobo PM, Michmacher E, Vaisman M. Metabolism; 2008 Jan 30; 57(1):121-9. PubMed ID: 18078869 [Abstract] [Full Text] [Related]
5. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. Spielhagen C, Schwahn C, Möller K, Friedrich N, Kohlmann T, Moock J, Kołtowska-Häggström M, Nauck M, Buchfelder M, Wallaschofski H. Growth Horm IGF Res; 2011 Feb 30; 21(1):1-10. PubMed ID: 21093334 [Abstract] [Full Text] [Related]
6. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A. Growth Horm IGF Res; 2008 Aug 30; 18(4):307-17. PubMed ID: 18282776 [Abstract] [Full Text] [Related]
7. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency. Benedini S, Dalle Carbonare L, Albiger N, Scanarini M, Bilora F, Petrobelli F, Giannini S, Mantero F, Scaroni C. Horm Metab Res; 2006 Jan 30; 38(1):16-21. PubMed ID: 16477535 [Abstract] [Full Text] [Related]
11. Effects of adult growth hormone deficiency and growth hormone replacement on circadian rhythmicity. White HD, Ahmad AM, Vora JP. Minerva Endocrinol; 2003 Mar 30; 28(1):13-25. PubMed ID: 12621360 [Abstract] [Full Text] [Related]
12. Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study. Lamberts SW. J Endocrinol Invest; 2008 Sep 30; 31(9 Suppl):2-5. PubMed ID: 19020377 [Abstract] [Full Text] [Related]
13. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB, Monson JP. Clin Endocrinol (Oxf); 2007 Jan 30; 66(1):72-7. PubMed ID: 17201804 [Abstract] [Full Text] [Related]
14. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency]. Olsovská V, Siprová H, Beránek M, Soska V. Vnitr Lek; 2005 Dec 30; 51(12):1356-64. PubMed ID: 16430102 [Abstract] [Full Text] [Related]
15. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem. Losa M, Gatti E, Rossini A, Lanzi R. J Endocrinol Invest; 2008 Sep 30; 31(9 Suppl):75-8. PubMed ID: 19020392 [Abstract] [Full Text] [Related]
16. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD]. Arita K, Hirano H, Tominaga A, Kurisu K. Brain Nerve; 2008 Dec 30; 60(12):1445-54. PubMed ID: 19110756 [Abstract] [Full Text] [Related]
17. [Benefits and risks of growth hormone in adults with growth hormone deficiency]. Díez JJ, Cordido F. Med Clin (Barc); 2014 Oct 21; 143(8):354-9. PubMed ID: 24485161 [Abstract] [Full Text] [Related]
18. Transition of childhood-onset growth hormone-deficient patients to adult healthcare. Rapaport R, Cook DM. Pediatr Endocrinol Rev; 2006 Dec 21; 4 Suppl 1():82-90. PubMed ID: 17261975 [Abstract] [Full Text] [Related]
19. Metabolic implications of growth hormone therapy. Perrini S, Carreira MC, Conserva A, Laviola L, Giorgino F. J Endocrinol Invest; 2008 Sep 21; 31(9 Suppl):79-84. PubMed ID: 19020393 [Abstract] [Full Text] [Related]
20. Growth hormone treatment for short stature in children born small for gestational age. Jung H, Rosilio M, Blum WF, Drop SL. Adv Ther; 2008 Oct 21; 25(10):951-78. PubMed ID: 18836868 [Abstract] [Full Text] [Related] Page: [Next] [New Search]